Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)

Clinical trial NCT00431145 · UNKNOWN

Trial details

NCT number: NCT00431145
Sponsor: Ludwig-Maximilians - University of Munich
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2006-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.